← All themes Genomics & Gene Editing

Gene Therapy

Gene therapy delivers a working copy of a gene, or a correction to a faulty one, usually once and for life. Manufacturing the delivery vector is often harder than designing the therapy.

131 stocks

#	Name	Funds holding	Growth	Growth %	Fund value
26	26 Sana Biotechnology SANA $733M	125	+9	+8%	$770M
27	27 Caribou Biosciences CRBU $48M	113	-7	-6%	$457M
28	28 DELISTED Generation Bio GBIO	111	+20	+22%	$306M
29	29 Lineage Cell Therapeutics LCTX $246M	105	+4	+4%	$73.1M
30	30 Nkarta NKTX $140M	105	-10	-9%	$562M
31	31 Adicet Bio ACET $47.6M	102	+1	+1%	$591M
32	32 Precision BioSciences DTIL $168M	102	-17	-14%	$68.6M
33	33 MeiraGTx Holdings MGTX $938M	100	-8	-7%	$234M
34	34 Cartesian Therapeutics RNAC $199M	96	+4	+4%	$105M
35	35 Instil Bio TIL $43.2M	95	-3	-3%	$577M
36	36 Lyell Immunopharma LYEL $203M	93	+18	+24%	$823M
37	37 4D Molecular Therapeutics FDMT $696M	88	-1	-1%	$210M
38	38 Lakefront Biotherapeutics American Depositary Shares LKFT $1.97B	83	+2	+2%	$551M
39	TCRR 39 DELISTED TCR2 Therapeutics Inc. Common Stock TCRR	81	-2	-2%	$45.1M
40	40 DELISTED Adverum Biotechnologies ADVM	78	+1	+1%	$55.6M
41	41 Passage Bio PASG $12.5M	75	-10	-12%	$49.3M
42	42 DELISTED Arcellx ACLX	74	+6	+9%	$782M
43	43 Tenaya Therapeutics TNYA $94.6M	73	+23	+46%	$102M
44	ATNX 44 DELISTED Athenex, Inc. Common Stock ATNX	72	-4	-5%	$13M
45	45 Celularity CELU $42.5M	72	+6	+9%	$81.1M
46	46 Voyager Therapeutics VYGR $126M	69	-9	-12%	$143M
47	ADAP 47 DELISTED Adaptimmune Therapeutics ADAP	68	-9	-12%	$122M
48	48 DELISTED Carisma Therapeutics CARM	68	-5	-7%	$11M
49	49 DELISTED Poseida Therapeutics, Inc. Common Stock PSTX	68	+12	+21%	$142M
50	50 Mustang Bio MBIO $2.88M	67	-4	-6%	$6.8M